Sean Mackay - Oct 7, 2021 Form 3 Insider Report for IsoPlexis Corp (ISO)

Role
Chief Executive Officer, Director
Signature
/s/ Shane Sevier, attorney-in-fact for Sean Mackay
Stock symbol
ISO
Transactions as of
Oct 7, 2021
Transactions value $
$0
Form type
3
Date filed
10/7/2021, 04:59 PM
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ISO Common Stock 799K Oct 7, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 40K $0.28 Direct F1
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 80K $0.28 Direct F2
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 52K $0.44 Direct F3
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 14K $0.73 Direct F4
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 14K $0.73 Direct F5
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 112K $0.73 Direct F6
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 24K $0.73 Direct F7
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 48K $0.73 Direct F8
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 52K $0.73 Direct F9
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 40K $0.73 Direct F10
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 96K $0.96 Direct F11
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 680K $1.03 Direct F12
holding ISO Stock Option (right to buy) Oct 7, 2021 Common Stock 744K $4.81 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 40,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on August 31, 2019 and the remainder vesting in 36 equal installments every month thereafter.
F2 Represents 80,000 time-vesting options. Time-vesting options were subject to a four-year time-based vesting schedule, with 25% vested on May 25, 2017 and the remainder vested in 36 equal installments every month thereafter.
F3 Represents 52,000 time-vesting options. Time-vesting options were subject to a four-year time-based vesting schedule, with 25% vested on October 20, 2017 and the remainder vested in 36 equal installments every month thereafter.
F4 Represents 14,000 performance-vesting options. Performance-vesting options are subject to vesting based upon the achievement of a 2018 revenue target, which was achieved, and a four-year time-based vesting schedule, with 25% vested on December 26, 2019 and the remainder vesting in 36 equal installments every month thereafter.
F5 Represents 14,000 performance-vesting options. Performance-vesting options are subject to vesting based upon the achievement of specified sales goals that remain outstanding and a four-year time-based vesting schedule, with 25% vesting on the first anniversary of the date the specified sales goals are achieved and the remainder vesting in 36 equal installments every month thereafter.
F6 Represents 112,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on October 5, 2018 and the remainder vesting in 36 equal installments every month thereafter.
F7 Represents 24,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on January 16, 2019 and the remainder vesting in 36 equal installments every month thereafter.
F8 Represents 48,000 time-vesting options. Time-vesting options were subject to a four-year time-based vesting schedule, with 25% vested on August 1, 2018 and the remainder vested in 36 equal installments every month thereafter.
F9 Represents 52,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on June 29, 2019 and the remainder vesting in 36 equal installments every month thereafter.
F10 Represents 40,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on September 27, 2019 and the remainder vesting in 36 equal installments every month thereafter.
F11 Represents 96,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on December 5, 2019 and the remainder vesting in 36 equal installments every month thereafter.
F12 Represents 680,000 performance-vesting options. Performance-vesting options were subject to vesting based upon the achievement of certain 2020 revenue targets. On December 15, 2020, the board of directors of IsoPlexis Corporation fully accelerated the performance-vesting options such that such options became exercisable as of such date.
F13 Represents 744,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vesting on June 8, 2022 and the remainder vesting in 36 equal installments every month thereafter.

Remarks:

Exhibit 24 - Power of Attorney